Pain relief medicine added to numbing drug for gallbladder surgery
Treatments studied
Part of Pain clinical trials.
This trial tests if adding dexmedetomidine or magnesium to a standard numbing medication (bupivacaine) injected into the belly during gallbladder surgery can improve pain control and recovery. It aims to find a better way to manage pain after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You are scheduled for elective gallbladder removal surgery (laparoscopic cholecystectomy) under general anesthesia.
- You are in good health or have mild health issues (ASA I or II).
- You do not have allergies to any of the study drugs.
- You do not have a history of heart rhythm problems or conduction issues.
- You do not have severe liver or kidney disease.
- You are not currently taking strong pain medications (opioids) or other painkillers regularly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two pain medicines added to a standard numbing shot (bupivacaine) for gallbladder surgery done through small incisions (laparoscopic cholecystectomy). The goal is to see which medicine provides better pain control after surgery.
This trial tests if a sedative called dexmedetomidine can lower the amount of anesthetic (sevoflurane) needed to block body responses during keyhole gallbladder surgery. If it works, it may make anesthesia safer for patients.
This study compares two ways to manage pain during laparoscopic gallbladder removal: one using opioids and one without. The goal is to see if pain control can be as effective without opioids, which may have fewer side effects.
This study tests a nerve block for pain after laparoscopic gallbladder removal. It compares different volumes of numbing medicine to find the best dose.
This study tests if adding a calming medicine (dexmedetomidine) during surgery can reduce the amount of a strong, short-acting painkiller (remifentanil) needed. It may help you have a smoother recovery with fewer side effects.
This trial studies a two-part pain pump given through a vein during major laparoscopic abdominal surgery to help control pain with general anesthesia. It may help by improving comfort while also avoiding certain side effects for people who can safely receive the study medicine.
Hear when a new Dexmedetomidine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.